Brain Cancer News and Features

Therapeutic vaccine for brain cancer being studied

January 24, 2012

A vaccine for people newly diagnosed with glioblastoma multiforme—the most aggressive and highest-grade malignant glioma—is being tested at 20 sites nationwide in a phase II trial.
 

Bevacizumab delays return of ovarian cancer

Delicia Honen Yard January 13, 2012

The use of bevacizumab (Avastin) improved progression-free survival in women with ovarian cancer, particularly those at high risk for disease progression.
 

New approach improves skull-base tumor surgery

December 16, 2011

A new transvestibular endoscopic method for removing tumors at the base of skull features shorter operation and recovery periods, fewer complications, and no scars.
 

Arginine may combat immunosuppression in glioblastoma

Delicia Honen Yard December 06, 2011

A common amino acid may help restore function to cancer-fighting T-cells in persons with glioblastoma, say researchers.
 

LATE-BREAKING NEWS: FDA revokes Avastin breast cancer indication

Delicia Honen Yard November 18, 2011

The FDA has revoked its approval of the breast cancer indication for Avastin (bevacizumab). The anti-angiogenic therapy remains indicated for some colorectal, lung, brain, and kidney cancers.
 

Denmark results hold: Cell phones do not cause brain tumors

Delicia Honen Yard November 04, 2011

A large follow-up analysis of the complete Danish Cancer Registry showed no increased risk of tumors of the central nervous system, providing little evidence for a causal association.
 

FoxM1 protein may hold key to treatment of pediatric brain tumor

Delicia Honen Yard October 14, 2011

The regulatory protein FoxM1 is essential for the continued growth of medulloblastoma and is significantly and negatively correlated with survival, making it a useful prognostic marker.
 

Bevacizumab label now warns of ovarian, osteonecrosis risks

Delicia Honen Yard October 12, 2011

The FDA has announced labeling changes for bevacizumab (Avastin), indicated for the treatment of glioblastoma and colorectal, breast, kidney, and nonsquamous non-small cell lung cancers.
 

Anti-inflammatory may combat glioma-related seizures

Delicia Honen Yard October 06, 2011

Epileptic seizures—common among people with primary brain tumors—may be related to the release of excess levels of glutamate, and may be controlled with the drug sulfasalazine.
 

Antiseizure medications can affect survival in glioblastoma

Delicia Honen Yard September 05, 2011

Patients with glioblastoma—the most common and most malignant form of brain tumor in adults—may live longer if they take valproic acid rather than another type of agent to control seizures.
 

Brain Cancer Clinical Trials

Clinical Trial: Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors

Clinical Trial: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Clinical Trial: High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors

Clinical Trial: Yoga Therapy in Treating Patients With Malignant Brain Tumors

Clinical Trial: BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor (CONDR)

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions